Viking Therapeutics(DE:1VT)
€25.60-0.60 (-2.29%)
DE:1VT
Viking Therapeutics earnings date
€25.60
At close:-0.60 (-2.29%)
Viking Therapeutics (1VT) Q2 2022 Earnings Report
76 Followers
DE:1VT Q2 2022 EPS Results
- Actual EPS
- -EUR 0.21
- Consensus EPS
- -EUR 0.19
- Beat/Miss
- Missed by -EUR 0.02
- One Year Ago EPS
- -EUR 0.18
DE:1VT Q2 2022 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 07/27/2022
- Time
- After Close
- Conference Call
- Wednesday, July 27, 2022
DE:1VT Upcoming Earnings
Viking Therapeutics's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1VT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2026 (Q4) | -1.24- | -1.25 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | -0.96-1.40 | -0.73 | -91.36% (-0.67) | |
| Jul 29, 2026 | 2026 (Q2) | -1.11-0.99 | -0.52 | -89.66% (-0.47) | |
| Apr 29, 2026 | 2026 (Q1) | -0.88-1.24 | -0.37 | -234.15% (-0.87) | |
| Feb 11, 2026 | 2025 (Q4) | -0.80-1.25 | -0.29 | -331.25% (-0.96) | |
| Oct 22, 2025 | 2025 (Q3) | -0.64-0.73 | -0.2 | -268.18% (-0.53) | |
| Jul 24, 2025 | 2025 (Q2) | -0.40-0.52 | -0.18 | -190.00% (-0.34) | |
| Apr 23, 2025 | 2025 (Q1) | -0.30-0.37 | -0.24 | -57.69% (-0.14) | |
| Feb 05, 2025 | 2024 (Q4) | -0.25-0.29 | -0.23 | -28.00% (-0.06) | |
| Oct 23, 2024 | 2024 (Q3) | -0.22-0.20 | -0.21 | 4.35% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
